Cipher Pharmaceuticals Inc.

TSX:CPH Stock Report

Market Cap: CA$327.5m

Cipher Pharmaceuticals Management

Management criteria checks 2/4

Cipher Pharmaceuticals' CEO is Craig Mull, appointed in Jul 2019, has a tenure of 5.33 years. directly owns 3.19% of the company’s shares, worth CA$10.46M. The average tenure of the management team and the board of directors is 2.5 years and 3.5 years respectively.

Key information

Craig Mull

Chief executive officer

US$1.0m

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownership3.2%
Management average tenure2.5yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

CEO

Craig Mull

5.3yrs

Tenure

US$1,045,700

Compensation

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...

Leadership Team

NamePositionTenureCompensationOwnership
Craig Mull
Interim CEO & Chairman of the Board5.3yrsUS$1.05m3.19%
CA$ 10.5m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 64.0k
Emilio Presti
Director of Sales & Marketing2.8yrsno datano data
Hamed Ghanei
Chief Business Officerless than a yearno datano data

2.5yrs

Average Tenure

Experienced Management: CPH's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Craig Mull
Interim CEO & Chairman of the Board5.7yrsUS$1.05m3.19%
CA$ 10.5m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.43%
CA$ 4.7m
Douglas Deeth
Independent Director1.4yrsUS$65.57kno data
Hubert Walinski
Independent Director1.4yrsUS$62.57kno data

3.5yrs

Average Tenure

Experienced Board: CPH's board of directors are considered experienced (3.5 years average tenure).